Literature DB >> 14161766

URINARY HYDROXYPROLINE EXCRETION IN METASTATIC CANCER OF BONE.

W D PLATT, L H DOOLITTLE, J W HARTSHORN.   

Abstract

Entities:  

Keywords:  BLOOD ACID PHOSPHATASE; BONE NEOPLASMS; BREAST NEOPLASMS; CLINICAL RESEARCH; COLLAGEN; HYDROXYPROLINE; NEOPLASM DIAGNOSIS; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; URINE

Mesh：

Substances：

Year:  1964        PMID： 14161766     DOI： 10.1056/NEJM196408062710604

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Urinary hydroxyproline in the management of breast cancer.

Authors:  A Cuschieri
Journal:  World J Surg       Date:  1977-05       Impact factor: 3.352

2.  Urinary hydroxyproline excretion in carcinoma of the breast.

Authors:  A Cuschieri; R A Felgate
Journal:  Br J Exp Pathol       Date:  1972-06

3.  Urinary total hydroxyproline: creatinine ratio. Range of normal, and clinical application in British children.

Authors:  B A Wharton; G Gough; A Williams; S Kitts; C A Pennock
Journal:  Arch Dis Child       Date:  1972-02       Impact factor: 3.791

4.  Total urinary hydroxyproline excretion in osteomalacia.

Authors:  J Anderson; D W Bannister; V Parsons; R W Tomlinson
Journal:  Calcif Tissue Res       Date:  1967-12-20

5.  [The behavior of the "collagen-like protein" in serum of patients with seleroderma before and following treatment with gestagens].

Authors:  H Holzmann; G W Korting; B Morsches; A Schlaudecker
Journal:  Arch Klin Exp Dermatol       Date:  1967

6.  Effect of mithramycin on calcium and hydroxyproline metabolism in patients with malignant disease.

Authors:  V Parsons; M Baum; M Self
Journal:  Br Med J       Date:  1967-02-25

7.  Urinary excretion of glycosaminoglycans in disseminated neoplasm.

Authors:  G Manley; L Bower; A Anson
Journal:  J Clin Pathol       Date:  1978-05       Impact factor: 3.411

8.  Variations in human urinary O-hydroxylysyl glycoside levels and their relationship to collagen metabolism.

Authors:  J P Segrest; L W Cunningham
Journal:  J Clin Invest       Date:  1970-08       Impact factor: 14.808

9.  Study of hydroxyproline excretion in patients with prostatic cancer.

Authors:  I Romics; I Budavári; L Kisbenedek; F Balogh
Journal:  Int Urol Nephrol       Date:  1981       Impact factor: 2.370

10.  Relevance of hydroxyproline excretion to bone metastasis in breast cancer.

Authors:  F Gielen; J Dequeker; A Drochmans; J Wildiers; M Merlevede
Journal:  Br J Cancer       Date:  1976-09       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.